Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 1.29B P/E - EPS this Y -14.80% Ern Qtrly Grth -
Income -49.53M Forward P/E -37.00 EPS next Y 12.90% 50D Avg Chg -14.00%
Sales 187.12M PEG - EPS past 5Y - 200D Avg Chg -12.00%
Dividend N/A Price/Book 8.20 EPS next 5Y - 52W High Chg -25.00%
Recommedations 1.90 Quick Ratio 3.61 Shares Outstanding 61.94M 52W Low Chg 20.00%
Insider Own 25.91% ROA -15.59% Shares Float 44.28M Beta 0.28
Inst Own 67.55% ROE -49.91% Shares Shorted/Prior 2.64M/3M Price 21.09
Gross Margin 81.20% Profit Margin -26.47% Avg. Volume 363,895 Target Price 15.86
Oper. Margin -10.78% Earnings Date May 7 Volume 422,233 Change -3.79%
About Treace Medical Concepts, Inc.

Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty 3D bunion correction system that combines instruments, implants, and surgical methods designed to surgically correct three planes of the bunion deformity. It also provides Lapiplasty mini-incision system designed to allow the Lapiplasty procedure to be performed through a 3.5cm incision. In addition, the company offers Adductoplasty system designed for reproducible realignment, stabilization, and fusion of the midfoot. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida.

Treace Medical Concepts, Inc. News
04/17/24 Treace to Present at Bank of America Health Care Conference
04/16/24 Treace Announces First Annual National Bunion Day
04/09/24 Treace to Report First Quarter 2024 Financial Results
03/25/24 Treace Celebrates 100,000 Lapiplasty® 3D Bunion Correction® Patient Milestone
03/01/24 Treace Medical Concepts, Inc. (NASDAQ:TMCI) Just Reported And Analysts Have Been Lifting Their Price Targets
02/29/24 Treace Medical Concepts, Inc. (NASDAQ:TMCI) Q4 2023 Earnings Call Transcript
02/29/24 Treace Medical Concepts Full Year 2023 Earnings: EPS Misses Expectations
02/27/24 Treace Medical Concepts (TMCI) Reports Q4 Loss, Tops Revenue Estimates
02/27/24 Treace Medical Concepts Inc (TMCI) Reports Robust Revenue Growth and Expands Surgeon Base in Q4 ...
02/27/24 Treace Medical Concepts Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides 2024 Guidance
02/20/24 Earnings Preview: Treace Medical Concepts (TMCI) Q4 Earnings Expected to Decline
02/07/24 Treace to Report Fourth Quarter and Full-Year 2023 Financial Results
02/02/24 Treace Announces Interim 3-Year ALIGN3D™ Clinical Study Data at the 2024 ACFAS Scientific Conference Demonstrating Sustained, Positive Outcomes of the Lapiplasty® Procedure
02/01/24 Treace to Highlight Latest Product Innovations and ALIGN3D™ Study Outcomes at the 2024 ACFAS Annual Scientific Conference
01/08/24 Treace Announces Preliminary, Unaudited Fourth Quarter and Full-Year 2023 Revenue
12/19/23 Treace to Present at 42nd Annual J.P. Morgan Healthcare Conference
12/07/23 Does the New Anti-Obesity Medicine Affect Treace Medical Concepts (TMCI)?
11/12/23 Treace Medical Concepts, Inc. (NASDAQ:TMCI) Q3 2023 Earnings Call Transcript
11/10/23 Q3 2023 Treace Medical Concepts Inc Earnings Call
11/09/23 Treace Medical Concepts Reports Third Quarter 2023 Financial Results
TMCI Chatroom

User Image Stock_Titan Posted - 6 days ago

$TMCI Treace to Present at Bank of America Health Care Conference https://www.stocktitan.net/news/TMCI/treace-to-present-at-bank-of-america-health-care-m8nss3lpolq5.html

User Image DonCorleone77 Posted - 1 week ago

$TMCI I was wondering why we didn't have a Nation Bunion Day before now :o) Treace Medical announces first annual National Bunion Day Treace Medical Concepts announced the first-ever National Bunion Day in the United States. National Bunion Day is an opportunity to help more people learn about the identification and treatment of this common bone deformity in the foot, which often includes debilitating pain for millions of adults in the U.S.

User Image Stock_Titan Posted - 1 week ago

$TMCI Treace Announces First Annual National Bunion Day https://www.stocktitan.net/news/TMCI/treace-announces-first-annual-national-bunion-h9yqjl7kwyrl.html

User Image airbell Posted - 1 week ago

$MGRM $NVDA $TMCI 🤑🔥💥

User Image Stock_Titan Posted - 2 weeks ago

$TMCI Treace to Report First Quarter 2024 Financial Results https://www.stocktitan.net/news/TMCI/treace-to-report-first-quarter-2024-financial-5m06jzsyleo0.html

User Image insiderbuyingselling Posted - 03/29/24

$TMCI new insider selling: 50000 shares. http://insiderbuyingselling.com/?t=TMCI

User Image DonCorleone77 Posted - 03/25/24

$TMCI National Bunion Day?: Treace announces 100,000 patients treated with Lapiplasty 3D Bunion Correction Treace Medical Concepts announced that 100,000 patients have been treated with its patented Lapiplasty 3D Bunion Correction System. This milestone coincides with the first-ever National Bunion Day in the United States, which is being sponsored by Treace on April 16, 2024, and the launch of its new patient education and brand awareness campaign.

User Image StockInvest_us Posted - 1 month ago

Signal alert: $TMCI - Oversold Trend Short (Undervalued) https://stockinvest.us/l/CbQAmaIhe6

User Image Stock_Titan Posted - 02/27/24

$TMCI Treace Medical Concepts Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides 2024 Guidance https://www.stocktitan.net/news/TMCI/treace-medical-concepts-reports-fourth-quarter-and-full-year-2023-tjellv80fk98.html

User Image TickerDD_com Posted - 02/26/24

From 2/13/2024, looking back across 22 Month-Ends for TMCI, Percentage Change of Average Monthly Price had More Negatives (55%) while Percentage Change of Average Monthly Volume had All Positives (100%) $TMCI #TMCI #TMCIStock #TickerDD #TMCIPrice https://www.youtube.com/watch?v=9uxD1VE702A

User Image kgnfdeagle Posted - 2 months ago

$TMCI Bought 200 shares at $15.25 today; Zacks Homerun pick from Brian Bolan.

User Image Stock_Titan Posted - 2 months ago

$TMCI Treace to Report Fourth Quarter and Full-Year 2023 Financial Results https://www.stocktitan.net/news/TMCI/treace-to-report-fourth-quarter-and-full-year-2023-financial-eigyw3kivouu.html

User Image DonCorleone77 Posted - 2 months ago

$TMCI Treace to show product innovations, ALIGN3D study outcomes at ACFAS conference Treace Medical Concepts will highlight new technology innovations and three-year interim ALIGN3D clinical results at the 2024 American College of Foot and Ankle Surgeons Annual Scientific Conference in Tampa, Florida from February 1-4, 2024. Treace will feature its current and next-generation technologies at its ACFAS exhibit booth and host Lapiplasty and Adductoplasty surgeon training events featuring recent innovations.

User Image StockInvest_us Posted - 01/31/24

Signal alert: $TMCI - Overbought Trend Short (Overvalued) https://stockinvest.us/l/XaGv9qIfAO

User Image InsiderFinance Posted - 3 months ago

🚨 Heavy institutional volume on $TMCI! Options trading 3.8x the daily average, ranking 14 on 🔥 INSIDERFINANCE.IO 🔥 Explore more ➡ @InsiderFinance. Snapshot: - Ticker: $TMCI - Momentum Rank: 14 - Volume Surge: 3.8x daily avg 👇 Dive into the options contracts and market analysis in the below screenshot from InsiderFinance's award-nominated trading toolkit.

User Image InsiderFinance Posted - 3 months ago

🚨 Heavy institutional volume on $TMCI! Options trading 3.8x the daily average, ranking 14 on 🔥 INSIDERFINANCE.IO 🔥 Explore more ➡ @InsiderFinance. Snapshot: - Ticker: $TMCI - Momentum Rank: 14 - Volume Surge: 3.8x daily avg 👇 Dive into the options contracts and market analysis in the below screenshot from InsiderFinance's award-nominated trading toolkit.

User Image tickeron Posted - 3 months ago

Wow this is a big change! $TMCI entered a Downtrend because Momentum Indicator dropped below the 0 level. View odds of downtrend. https://srnk.us/go/4967671

User Image Last10K Posted - 3 months ago

$TMCI just filed with the SEC a Regulated Disclosure and a Financial Exhibit https://last10k.com/sec-filings/TMCI/0000950170-24-003448.htm?utm_source=stocktwits&utm_medium=forum&utm_campaign=8K&utm_term=TMCI

User Image risenhoover Posted - 3 months ago

$TMCI / Treace Medical Concepts files form 8-K - UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 9, 2024 TREACE MEDICAL CO https://fintel.io/doc/sec-treace-medical-concepts-inc-1630627-8k-2024-january-10-19732-1473?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=filing

User Image StockAutomatePro Posted - 3 months ago

$TMCI Looks like the stock may experience a surge chart analysis confirms. We alerted the BUY signal at $11.77 and we were able to close this one with profit at $13.46🤙

User Image ChartMill Posted - 3 months ago

$KYMR, $CRDO, $CRNX and $TMCI are the top gainers for the day. https://www.chartmill.com/stock/stock-screener?v=3&f=sl_pt_4_X,p_pg10,v1_50b500,exch_us&s=pt&utm_source=top_gainers&utm_medium=stocktwits&utm_campaign=screen

User Image EarningsInsider Posted - 3 months ago

$TMCI updates Q4 2023 guidance to EPS and revenue guidance to $61.8 million-$62.2 million. www.marketbeat.com/stocks/NASDAQ/TMCI/earnings/

User Image OpenOutcrier Posted - 3 months ago

$TMCI (+15.6% pre) Treace Announces Preliminary, Unaudited Fourth Quarter and Full-Year 2023 Revenue - 8k https://ooc.bz/l/21535

User Image Last10K Posted - 3 months ago

$TMCI just filed with the SEC a Earnings Release and a Financial Exhibit https://last10k.com/sec-filings/TMCI/0000950170-24-002719.htm?utm_source=stocktwits&utm_medium=forum&utm_campaign=8K&utm_term=TMCI

User Image MyCompassTrading Posted - 3 months ago

Gapping up In reaction to earnings/guidance: $TMCI +28.3% (guidance), AXNX +21.3% (guidance), RXST +8.4% (guidance), AKYA +8.3% (guidance), CROX +7.8% (guidance), CALT +5.5% (guidance)

User Image cctranscripts Posted - 3 months ago

TREACE MEDICAL CONCEPTS: Treace Announces Preliminary, Unaudited Fourth Quarter And Full-Year 2 https://www.conferencecalltranscripts.org/summary/?id=12849260 $TMCI

User Image risenhoover Posted - 3 months ago

$TMCI / Treace Medical Concepts files form 8-K - UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 8, 2024 TREACE MEDICAL CO https://fintel.io/doc/sec-treace-medical-concepts-inc-1630627-8k-2024-january-08-19730-620?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=filing

User Image DonCorleone77 Posted - 3 months ago

$TMCI 2 of 2 - Treace Medical sees Q4 revenue $61.8M-$62.2M, consensus $58.89M ....and 82% revenue contribution in the fourth quarter of 2023."We delivered another year of significant progress in 2023 and expect to remain on track to drive strong growth and profitably scale our business in the years ahead," said John T. Treace, CEO. "We believe we are driving a market conversion in a large, underserved market as the fastest-growing, publicly-traded company in foot and ankle with differentiated bunion, midfoot, and related complementary technologies. We also believe we are in a great position strategically with an expanding addressable market opportunity with new technologies, such as our Adductoplasty, Hammertoe and SpeedPlate products, and more innovations to come, supported by differentiating clinical studies, continued strong additions to our surgeon base and a powerful, focused commercial organization...."

User Image DonCorleone77 Posted - 3 months ago

$TMCI 1 of 2 - Treace Medical sees Q4 revenue $61.8M-$62.2M, consensus $58.89M Preliminary revenue of $186.7 million to $187.1 million for the full-year 2023, an approximate increase of 32% at the midpoint compared to the prior year and above the high end of the previously provided revenue guidance range of $182 million to $186 million. Preliminary blended average revenue per Lapiplasty procedure kit sold in the fourth quarter of 2023 was approximately $6,437, a record high and 9% increase over the same period in 2022. Substantial new active surgeon additions of approximately 164 in the fourth quarter of 2023 and approximately 468 for full-year 2023; Ended the year with approximately 2,855 active surgeons, a 20% increase compared to the prior year and approximately 29% of the estimated 10,000 U.S. surgeons performing bunion surgery. Ended the fourth quarter of 2023 with 227 direct quota carrying sales representatives, a 35% increase over year-end 2022....

User Image Stock_Titan Posted - 3 months ago

$TMCI Treace Announces Preliminary, Unaudited Fourth Quarter and Full-Year 2023 Revenue https://www.stocktitan.net/news/TMCI/treace-announces-preliminary-unaudited-fourth-quarter-and-full-year-9uql3hau7tep.html

Analyst Ratings
Truist Securities Buy Dec 22, 23
Morgan Stanley Overweight Nov 13, 23
Stifel Buy Nov 10, 23
Truist Securities Buy Nov 10, 23
Stifel Buy Oct 2, 23
UBS Buy Sep 29, 23
Stephens & Co. Equal-Weight Sep 12, 23
BTIG Buy Aug 28, 23
Stephens & Co. Equal-Weight Aug 10, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Scanlan Sean F. Chief Innovation Off.. Chief Innovation Officer May 16 Sell 25.44 25,000 636,000 32,395 05/18/23
Scanlan Sean F. Chief Innovation Off.. Chief Innovation Officer May 16 Option 0.1 25,000 2,500 57,395 05/18/23
TREACE JAMES T Director Director Apr 28 Sell 25.32 50,000 1,266,000 861,441 05/02/23
BAYS F BARRY Director Director Apr 26 Sell 25.45 27,804 707,612 1,090,821 04/28/23
BAYS F BARRY Director Director Apr 11 Sell 26.56 86,160 2,288,410 1,118,625 04/13/23
MOTT RICHARD W Director Director Apr 06 Sell 26.0008 4,043 105,121 905,000 04/10/23
MOTT RICHARD W Director Director Apr 03 Sell 26 15,957 414,882 909,043 04/05/23
MOTT RICHARD W Director Director Mar 30 Sell 25.68 133,498 3,428,229 925,000 03/31/23
TREACE JAMES T Director Director Mar 30 Sell 25.8634 50,000 1,293,170 911,441 03/31/23
BAYS F BARRY Director Director Mar 28 Sell 25.15 58,698 1,476,255 1,204,785 03/30/23
Owens Daniel E. Other Other Mar 15 Sell 22.87 6,250 142,938 30,914 03/17/23
Owens Daniel E. Other Other Mar 15 Option 7.03 6,250 43,938 37,164 03/17/23
TIMBIE THOMAS E Director Director Mar 15 Sell 23.0333 50,000 1,151,665 1,149,069 03/17/23
BAYS F BARRY Director Director Mar 13 Sell 24.02 18,800 451,576 1,263,483 03/15/23
Treace John T. Chief Executive Offe.. Chief Executive Offer Mar 09 Sell 24.41 2,075 50,651 5,539,380 03/10/23
Berutti Aaron Sr. VP, Sales Sr. VP, Sales Mar 09 Sell 24.41 733 17,893 13,042 03/10/23
Hair Mark Chief Financial Offi.. Chief Financial Officer Mar 09 Sell 24.41 1,040 25,386 27,110 03/10/23
Owens Daniel E. Other Other Mar 09 Sell 24.41 411 10,033 10,289 03/10/23
Scanlan Sean F. Chief Innovation Off.. Chief Innovation Officer Mar 09 Sell 24.41 505 12,327 9,470 03/10/23
Elder Scot Michael *See "Remarks" *See "Remarks" Mar 09 Sell 24.41 177 4,321 22,421 03/10/23
MOTT RICHARD W Director Director Mar 08 Sell 24.17 46,502 1,123,953 1,058,498 03/10/23
MOTT RICHARD W Director Director Mar 01 Sell 21.3509 50,000 1,067,545 1,105,000 03/03/23
TREACE JAMES T Director Director Feb 28 Sell 21.45 50,000 1,072,500 961,441 03/02/23
BAYS F BARRY Director Director Feb 21 Sell 21.86 18,800 410,968 1,282,283 02/23/23
Scanlan Sean F. Chief Innovation Off.. Chief Innovation Officer Feb 15 Option 0.1 25,000 2,500 34,975 02/17/23
Scanlan Sean F. Chief Innovation Off.. Chief Innovation Officer Feb 15 Sell 21.69 25,000 542,250 9,975 02/17/23
TIMBIE THOMAS E Director Director Feb 15 Sell 21.71 50,000 1,085,500 1,199,069 02/17/23
BAYS F BARRY Director Director Feb 07 Sell 22.35 36,531 816,468 1,301,083 02/09/23
MOTT RICHARD W Director Director Feb 02 Sell 24.00 4,011 96,264 1,155,000 02/03/23
TREACE JAMES T Director Director Jan 31 Sell 23.19 11,929 276,634 1,011,441 02/02/23
TREACE JAMES T Director Director Jan 30 Sell 23.74 38,071 903,806 1,023,370 01/30/23
MOTT RICHARD W Director Director Jan 30 Sell 23.79 90,989 2,164,628 1,159,011 01/30/23
BAYS F BARRY Director Director Jan 24 Sell 25.68 53,643 1,377,552 1,337,614 01/26/23
TIMBIE THOMAS E Director Director Jan 18 Sell 25.88 50,000 1,294,000 1,249,069 01/20/23
MOTT RICHARD W Director Director Jan 17 Sell 26.0012 11,014 286,377 1,250,000 01/19/23
Scanlan Sean F. Chief Innovation Off.. Chief Innovation Officer Jan 12 Sell 25.57 25,000 639,250 9,975 01/13/23
Scanlan Sean F. Chief Innovation Off.. Chief Innovation Officer Jan 12 Option 0.1 25,000 2,500 34,975 01/13/23
MOTT RICHARD W Director Director Jan 12 Sell 26 48,986 1,273,636 1,261,014 01/13/23
BAYS F BARRY Director Director Jan 11 Sell 25.13 55,255 1,388,558 1,391,257 01/13/23
MOTT RICHARD W Director Director Jan 05 Sell 24 20,000 480,000 1,310,000 01/09/23
MOTT RICHARD W Director Director Dec 30 Sell 22.6723 75,000 1,700,422 1,330,000 12/30/22
BAYS F BARRY Director Director Dec 19 Sell 23.05 18,481 425,987 1,481,333 12/21/22
TIMBIE THOMAS E Director Director Dec 14 Sell 23.9987 50,000 1,199,935 1,299,069 12/16/22
TREACE JAMES T Director Director Dec 12 Sell 24.183 25,000 604,575 1,061,441 12/14/22
BAYS F BARRY Director Director Dec 07 Sell 23.98 18,800 450,824 1,499,814 12/09/22
BAYS F BARRY Director Director Dec 07 Sell 23.98 18,800 450,824 1,499,814 12/09/22
MOTT RICHARD W Director Director Nov 30 Sell 22.95 95,000 2,180,250 1,405,000 12/02/22
Owens Daniel E. Chief Human Resource.. Chief Human Resources Officer Dec 02 Option 12.01 5,625 67,556 12,575 12/02/22
Owens Daniel E. Chief Human Resource.. Chief Human Resources Officer Dec 02 Sell 25 5,625 140,625 10,700 12/02/22
BAYS F BARRY Director Director Nov 28 Sell 22.13 18,800 416,044 1,518,614 11/30/22